Atlas Trials

Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.

Clinical trial NCT01845584 · COMPLETED

Trial details

NCT number
NCT01845584
Sponsor
Nihon Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorder
Start date
2013-05-01
Primary completion
2015-08-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.